0001616308-20-000001.txt : 20200803 0001616308-20-000001.hdr.sgml : 20200803 20200803141515 ACCESSION NUMBER: 0001616308-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200803 DATE AS OF CHANGE: 20200803 EFFECTIVENESS DATE: 20200803 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Reiley Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001616308 IRS NUMBER: 471097516 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-372355 FILM NUMBER: 201068837 BUSINESS ADDRESS: STREET 1: 367 SANTANA HEIGHTS #7007 CITY: SAN JOSE STATE: CA ZIP: 95128 BUSINESS PHONE: 408-718-9027 MAIL ADDRESS: STREET 1: 367 SANTANA HEIGHTS #7007 CITY: SAN JOSE STATE: CA ZIP: 95128 D 1 primary_doc.xml X0708 D LIVE 0001616308 Reiley Pharmaceuticals, Inc. 3749 Buchanan Street, Suite 475745 SAN FRANCISCO CA CALIFORNIA 94147 650-269-8044 DELAWARE None None Corporation true B. Michael Silber 3749 Buchanan Street Suite 475745 San Francisco CA CALIFORNIA 94147 Executive Officer Director Keith Valentine 3749 Buchanan Street Suite 475745 San Francisco CA CALIFORNIA 94147 Director Jeffrey Dunn 3749 Buchanan Street Suite 475745 San Francisco CA CALIFORNIA 94147 Director Pharmaceuticals Decline to Disclose 06b false 2020-07-21 false true true false 10000 1500000 1052868 447132 false 27 0 0 0 false Reiley Pharmaceuticals, Inc. B. Michael Silber, Ph.D. B. Michael Silber, Ph.D. CEO 2020-08-03